Biora Therapeutics, Inc. (BIOR)

0.7310 +0.0182 (+2.55%) 收市：04:00PM EDT

Biora Therapeutics, Inc.

4330 La Jolla Village Drive
Suite 300
San Diego, CA 92122
United States
833 727 2841
https://www.bioratherapeutics.com

版塊: Healthcare
行業: Biotechnology
全職員工: 58

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. Aditya P. Mohanty M.B.A.	CEO & Director	984.14k	無	1967
Mr. Eric d'Esparbes	Chief Financial Officer	748.26k	無	1968
Mr. Clarke Neumann J.D.	Senior VP, General Counsel & Secretary	724.62k	無	1964
Eric Fox	VP of Finance & Accounting & Treasurer	無	無	無
Mr. George Gianakopoulos	Senior Vice President of Sales	無	無	1961
Ms. Robyn Hatton	Head of Human Resources	無	無	無
Mr. Kevin Howe Ph.D.	Senior VP of Strategic Operations	無	無	無
Dr. Sharat Singh Ph.D.	Head of Research	無	無	1959
Dr. Paul Shabram M.B.A.	Head of Technical Operations	無	無	無
Ms. Ariella Kelman M.D.	Chief Medical Officer	無	無	無

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Biora Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California.

公司管治

截至 無 止，Biora Therapeutics, Inc. 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。